PTCH1 and triple-negative breast carcinoma: A higher ratio of PTCH1 mutations was found in luminal B breast cancer without Her-2/neu overexpression (67%) and triple-negative breast cancer (TNBC, 62%) compared with other subtypes (Table 4).